Cargando…
A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial
Medication deprescribing is essential to prevent inappropriate medication use in multimorbid patients. However, experience of deprescribing in Danish Subacute Medical Outpatient Clinics (SMOCs) is limited. The objective of our pilot study was to evaluate the feasibility and sustainability of a colla...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066016/ https://www.ncbi.nlm.nih.gov/pubmed/33808080 http://dx.doi.org/10.3390/metabo11040204 |
_version_ | 1783682476053364736 |
---|---|
author | Aharaz, Anissa Rasmussen, Jens Henning McNulty, Helle Bach Ølgaard Cyron, Arne Fabricius, Pia Keinicke Bengaard, Anne Kathrine Sejberg, Hayley Rose Constance Simonsen, Rikke Rie Løvig Treldal, Charlotte Houlind, Morten Baltzer |
author_facet | Aharaz, Anissa Rasmussen, Jens Henning McNulty, Helle Bach Ølgaard Cyron, Arne Fabricius, Pia Keinicke Bengaard, Anne Kathrine Sejberg, Hayley Rose Constance Simonsen, Rikke Rie Løvig Treldal, Charlotte Houlind, Morten Baltzer |
author_sort | Aharaz, Anissa |
collection | PubMed |
description | Medication deprescribing is essential to prevent inappropriate medication use in multimorbid patients. However, experience of deprescribing in Danish Subacute Medical Outpatient Clinics (SMOCs) is limited. The objective of our pilot study was to evaluate the feasibility and sustainability of a collaborative deprescribing intervention by a pharmacist and a physician to multimorbid patients in a SMOC. A randomized controlled pilot study was conducted, with phone follow-up at 30 and 365+ days. A senior pharmacist performed a systematic deprescribing intervention using the Screening Tool of Older Persons’ potentially inappropriate Prescriptions (STOPP) criteria, the Danish deprescribing list, and patient interviews. A senior physician received the proposed recommendations and decided which should be implemented. The main outcome was the number of patients having ≥1 medication where deprescribing status was sustained 30 days after inclusion. Out of 76 eligible patients, 72 (95%) were included and 67 (93%) completed the study (57% male; mean age 73 years; mean number of 10 prescribed medications). Nineteen patients (56%) in the intervention group and four (12%) in the control group had ≥1 medication where deprescribing status was sustained 30 days after inclusion (p = 0.015). In total, 37 medications were deprescribed in the intervention group and five in the control group. At 365+ days after inclusion, 97% and 100% of the deprescribed medications were sustained in the intervention and control groups, respectively. The three most frequently deprescribed medication groups were analgesics, cardiovascular, and gastrointestinal medications. In conclusion, a collaborative deprescribing intervention for multimorbid patients was feasible and resulted in sustainable deprescribing of medication in a SMOC. |
format | Online Article Text |
id | pubmed-8066016 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80660162021-04-25 A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial Aharaz, Anissa Rasmussen, Jens Henning McNulty, Helle Bach Ølgaard Cyron, Arne Fabricius, Pia Keinicke Bengaard, Anne Kathrine Sejberg, Hayley Rose Constance Simonsen, Rikke Rie Løvig Treldal, Charlotte Houlind, Morten Baltzer Metabolites Article Medication deprescribing is essential to prevent inappropriate medication use in multimorbid patients. However, experience of deprescribing in Danish Subacute Medical Outpatient Clinics (SMOCs) is limited. The objective of our pilot study was to evaluate the feasibility and sustainability of a collaborative deprescribing intervention by a pharmacist and a physician to multimorbid patients in a SMOC. A randomized controlled pilot study was conducted, with phone follow-up at 30 and 365+ days. A senior pharmacist performed a systematic deprescribing intervention using the Screening Tool of Older Persons’ potentially inappropriate Prescriptions (STOPP) criteria, the Danish deprescribing list, and patient interviews. A senior physician received the proposed recommendations and decided which should be implemented. The main outcome was the number of patients having ≥1 medication where deprescribing status was sustained 30 days after inclusion. Out of 76 eligible patients, 72 (95%) were included and 67 (93%) completed the study (57% male; mean age 73 years; mean number of 10 prescribed medications). Nineteen patients (56%) in the intervention group and four (12%) in the control group had ≥1 medication where deprescribing status was sustained 30 days after inclusion (p = 0.015). In total, 37 medications were deprescribed in the intervention group and five in the control group. At 365+ days after inclusion, 97% and 100% of the deprescribed medications were sustained in the intervention and control groups, respectively. The three most frequently deprescribed medication groups were analgesics, cardiovascular, and gastrointestinal medications. In conclusion, a collaborative deprescribing intervention for multimorbid patients was feasible and resulted in sustainable deprescribing of medication in a SMOC. MDPI 2021-03-30 /pmc/articles/PMC8066016/ /pubmed/33808080 http://dx.doi.org/10.3390/metabo11040204 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Aharaz, Anissa Rasmussen, Jens Henning McNulty, Helle Bach Ølgaard Cyron, Arne Fabricius, Pia Keinicke Bengaard, Anne Kathrine Sejberg, Hayley Rose Constance Simonsen, Rikke Rie Løvig Treldal, Charlotte Houlind, Morten Baltzer A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial |
title | A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial |
title_full | A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial |
title_fullStr | A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial |
title_full_unstemmed | A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial |
title_short | A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial |
title_sort | collaborative deprescribing intervention in a subacute medical outpatient clinic: a pilot randomized controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066016/ https://www.ncbi.nlm.nih.gov/pubmed/33808080 http://dx.doi.org/10.3390/metabo11040204 |
work_keys_str_mv | AT aharazanissa acollaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT rasmussenjenshenning acollaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT mcnultyhellebachølgaard acollaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT cyronarne acollaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT fabriciuspiakeinicke acollaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT bengaardannekathrine acollaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT sejberghayleyroseconstance acollaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT simonsenrikkerieløvig acollaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT treldalcharlotte acollaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT houlindmortenbaltzer acollaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT aharazanissa collaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT rasmussenjenshenning collaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT mcnultyhellebachølgaard collaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT cyronarne collaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT fabriciuspiakeinicke collaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT bengaardannekathrine collaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT sejberghayleyroseconstance collaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT simonsenrikkerieløvig collaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT treldalcharlotte collaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial AT houlindmortenbaltzer collaborativedeprescribinginterventioninasubacutemedicaloutpatientclinicapilotrandomizedcontrolledtrial |